Spectrum News| February 2025
Spectrum Equity Named a Top Growth Equity Firm of 2024

Boston, San Francisco, and London, February 13, 2025 - Spectrum Equity has been named to GrowthCap’s Top Growth Equity Firms of 2024.
Spectrum Equity has a uniquely collaborative, hands-on approach to partnership – for more than three decades, founders and leadership teams have benefited from the firm’s collective experience, curated network of experts, and committed support. The firm has invested in 175+ companies across multiple sectors, focusing on category-leading software, data, and consumer internet businesses.
With offices in Boston, San Francisco, and London, the firm is currently investing its tenth fund. Representative investments include AllTrails, Ancestry, Definitive Healthcare, GoodRx, Lucid Software, Teachers Pay Teachers, Origami Risk, and Verafin.
“For over 30 years, we’ve been privileged to support extraordinary companies and the people who make them possible," said Ben Spero, Spectrum Managing Director. "Partnering with founders and leadership teams means more than providing capital — it’s about helping them scale, navigate pivotal moments, and realize their ambitions.”
“The ability for a firm to create or enhance value for a portfolio company, and in parallel its limited partners, is table stakes,” said GrowthCap in their official statement. “At a much deeper level, the ability for a firm to consistently recruit the best talent, grow portfolio companies, and ultimately build a reputation that stands the test of time is much harder to attain.”
Read the full list of top growth equity firms here.
Spectrum Equity submitted the nomination to be considered for the GrowthCap Top Growth Equity Firm list and has paid a fee to promote/distribute this award after designation was announced 02/2025.
The GrowthCap “Top Growth Equity” award is issued by GrowthCap, an independent 3rd-party that is not affiliated with Spectrum Equity. Spectrum Equity paid a fee to GrowthCap in connection with the promotion and distribution of this announcement following the award designation. The award was announced Feb. 13th, 2025, and the time period for which the award was based Dec. 1st 2023-Dec 31st 2024. Spectrum Equity submitted the nomination for consideration on January 10th, 2025, along with information of the firm’s professional experience, strengths, and performance metrics. This award reflects GrowthCap’s determination based on its own criteria. For more information about GrowthCap and its award methodology, please visit www.growthcapadvisory.com. The award is not indicative of Spectrum Equity’s future performance and is not an endorsement by any client or investor.
The content on this site, including but not limited to blog posts, portfolio news, Spectrum news, and external coverage, is for informational purposes only and does not constitute investment advice. Use of any information presented is at your own risk. Spectrum Equity is not responsible for any content reposted above from any third party website, and has not verified the accuracy of any third party content contained above. Spectrum Equity makes no guarantees or other representations regarding any results that may be obtained from use of this content. Investment decisions should always be made in consultation with a financial advisor and based on individual research and due diligence. Past performance is not indicative of future results, and there is a possibility of loss in connection with an investment in any Spectrum Fund.
Inclusion in any third-party list, award, rating, ranking, or other recognition is not indicative of Spectrum Equity’s future performance and may not be representative of any investor’s experience. To the fullest extent permitted by law, Spectrum Equity disclaims all liability for any inaccuracies, omissions, or reliance on the information, analysis, or opinions presented.